Drug cost data suggest patient copays, compliance linked

In 2005, the top five therapeutic classes for prescribed drugs purchased by adults accounted for nearly two-thirds of total prescription drug expenses by adults, according to the Agency for Healthcare Research and Quality (AHRQ) in Rockville, MD. The AHRQ findings offer capitated provider organizations insights into prescription drug costs for the most widely used therapeutic classes, and suggest compliance issues for the most expensive drugs.